MLS MEDICAL A/S
Credit rating
Company information
About the company
MLS MEDICAL A/S (CVR number: 12455631) is a company from GRIBSKOV. The company recorded a gross profit of 3769 kDKK in 2022. The operating profit was -142 kDKK, while net earnings were -172.3 kDKK. The profitability of the company measured by Return on Assets (ROA) was -1.8 %, which can be considered poor and Return on Equity (ROE) was -3.7 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 78.5 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. MLS MEDICAL A/S's liquidity measured by quick ratio was 4.1 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | 5 113.77 | 4 716.58 | 4 178.08 | 3 545.09 | 3 768.99 |
EBIT | 469.01 | 413.19 | 346.27 | - 224.41 | - 142.01 |
Net earnings | 322.17 | 268.76 | 242.59 | - 187.62 | - 172.32 |
Shareholders equity total | 5 076.74 | 4 845.50 | 4 888.08 | 4 700.46 | 4 528.14 |
Balance sheet total (assets) | 6 826.57 | 6 578.72 | 6 571.16 | 6 087.02 | 6 053.83 |
Net debt | -2 250.09 | -2 839.17 | -3 252.80 | -2 685.51 | -2 931.18 |
Profitability | |||||
EBIT-% | |||||
ROA | 6.8 % | 6.5 % | 6.2 % | -2.8 % | -1.8 % |
ROE | 6.6 % | 5.4 % | 5.0 % | -3.9 % | -3.7 % |
ROI | 9.6 % | 8.2 % | 7.8 % | -3.5 % | -2.2 % |
Economic value added (EVA) | 220.27 | 192.93 | 176.55 | - 246.96 | - 206.67 |
Solvency | |||||
Equity ratio | 78.8 % | 76.7 % | 78.1 % | 85.0 % | 78.5 % |
Gearing | 3.1 % | 1.6 % | 3.3 % | 2.2 % | 1.8 % |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 3.6 | 3.3 | 3.8 | 6.1 | 4.1 |
Current ratio | 2.7 | 2.7 | 3.0 | 3.4 | 3.3 |
Cash and cash equivalents | 2 406.57 | 2 917.11 | 3 411.83 | 2 787.81 | 3 011.35 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | A | A | BBB | BBB | BBB |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.